F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing - The New York Times
- F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing The New York Times
- U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease CNBC
- The Download: inside the first CRISPR treatment, and smarter robots MIT Technology Review
- FDA approves two gene therapies for sickle cell, bringing hope to thousands with the disease CNN
- Listen: Sickle Cell Cure, Job Gains, More Bloomberg